Ex Vivo Activity of Cytotoxic Drugs and Targeted Agents in Small Intestinal Neuroendocrine Tumors
#2018
Introduction: Small Intestinal Neuroendocrine Tumours (SI-NETs) are considered to be generally resistant to systemic treatment. To date predictive markers for drug activity are lacking.
Aim(s): To profile SI-NETs with respect to sensitivity ex vivo to standard chemotherapeutics and targeted agents.
Materials and methods: Tumour samples from 27 patients with SI-NETs were analyzed ex vivo using a short-term total cell kill assay. Samples of renal cancer, colorectal cancer (CRC), ovarian cancer, and chronic lymphocytic leukemia (CLL) were included for comparison. For the SI-NET subset, drug sensitivity was analyzed in relation to clinicopathological variables.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Daskalakis K
Authors: Daskalakis K, Norlén O, Karakatsanis A, Hellman P, Larsson R,
Keywords: Ex vivo activity, Cytotoxic drugs, Targeted agents, small intestinal neuroendocrine tumors,
To read the full abstract, please log into your ENETS Member account.